Ethics declarations Conflicts of Interest Jessica Huston, Dontia Orey, Andrew Ashchi, Andrea Ashchi Lachapelle, Ariana Genovese, Jenna Jackson, Ramsey Ashchi, Towfeeq Ashchi, Majdi Ashchi, David Sutton, Wasim Deeb, and Rebecca F
Oral Wegovy at the higher 25 mg dose for weight loss was approved by the US FDA in December 2025
Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider
By combining FDA-approved medications with personalized nutrition plans and lifestyle guidance, this treatment targets the underlying causes of weight gain
This single mistake accounts for the largest share of reported overdoses